Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.76% | -44.16% | 20.29% | 5.66% | -504.89% |
| Total Depreciation and Amortization | 55.10% | 102.38% | 79.41% | 0.00% | 68.97% |
| Total Amortization of Deferred Charges | -9.26% | -8.55% | -8.52% | 73.92% | -- |
| Total Other Non-Cash Items | -39.93% | 166.40% | -97.28% | 169.38% | 135.60% |
| Change in Net Operating Assets | -38.55% | -66.23% | 176.71% | 84.91% | -73.00% |
| Cash from Operations | -65.12% | 4.00% | 33.35% | 60.63% | -338.67% |
| Capital Expenditure | 100.00% | 99.87% | 94.50% | 2,642.86% | -891.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 99.87% | 94.50% | 2,642.86% | -891.94% |
| Total Debt Issued | -100.00% | 100.00% | 0.00% | -- | 150.00% |
| Total Debt Repaid | -45.11% | 9.92% | 9.34% | -62.70% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | -- | -- | -- |
| Other Financing Activities | -63.59% | -- | -- | -- | -96.30% |
| Cash from Financing | -56.04% | 98.30% | -44.69% | 437.96% | -62.40% |
| Foreign Exchange rate Adjustments | 0.00% | -100.00% | 700.00% | 0.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.64% | 99.22% | -123.52% | 108.39% | -84.03% |